With respect, I have doubts about your assertion that the patent will prevent anyone else from capturing exosomes in the diagnosis and treatment of cancer. As I read it, the patent protects Aethlon's specific METHOD OF CAPTURE of exosomes, not the entire exosome field in oncology. And there are MANY methods of exosome capture (and have been for over 30 years)...
So why would anyone license Aethlon's specific method of capture?
News 
Market Data 
Discover 
